ClinicalTrials.gg
Not yet recruitingNCT06808191ulcer healingUpdated Feb 5, 2025

Effect of Magnetic Current on Ulcer Healing

An interventional study of pulsed electromagnetic currant machine and Placebo in Diabetic Foot Ulcer, sponsored by Beni-Suef University. Not yet recruiting at 1 site in Egypt. Open to participants aged 50 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-02-05.

Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
50 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Diabetic Foot with a site in Egypt — 7 open to participants now, 8 under way, none of them phase 3. Diabetic Foot · Egypt.

Planned enrollment
17th of 26
40 · median 49
Started
2025
with 5 others
No phase
21 of 30
6 open now
Registered
21st of 30
by date
Lead sponsor
1 of 30
Beni-Suef University

Among the 30 studies in Diabetic Foot with a site in Egypt, this one is the 17th largest by planned enrollment of the 26 interventional ones that give a count, is one of 6 that started in 2025, is one of 21 with no phase, and was the 21st registered.

Diabetic Foot

1,079 studies on the registry are indexed under Diabetic Foot; 221 are open to participants now.

Browse Diabetic Foot studies →

Open to participants now

7 of the 30 studies in Diabetic Foot with a site in Egypt are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 139 Diabetic Foot studies recruiting now, 98 (71%) set no upper age limit and 12 (9%) stop at 75 or younger; 5 take children under 18; 11 take healthy volunteers.

This study: 50 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Diabetic Foot with a site in Egypt, or all of them as a file.
02

Study summary

This study aims to evaluate the effectiveness of magnetic current in the management of DFUs as an alternative therapy on promoting the healing of chronic diabetic foot ulcers as compared with a control group.Twenty diabetic patients (n=40) affected with diabetic foot ulcer(s) will be recruited in the study and will be randomly allocated into two equal groups (20 patients in each group):

1- Group A: Pulsed electromagnetic field (PEMF) group. 2- Group B: Control group. Assessments of the healing of ulcers will be performed at the baseline, post-treatment evaluation (ie, after 14 treatment sessions), and 1-month follow-up.

:

Read the detailed description

This study aims to evaluate the effectiveness of magnetic current in the management of DFUs as an alternative therapy on promoting the healing of chronic diabetic foot ulcers as compared with a control group.Twenty diabetic patients (n=40) affected with diabetic foot ulcer(s) will be recruited in the study and will be randomly allocated into two equal groups (20 patients in each group):

  1. Group A: Pulsed electromagnetic field (PEMF) group.
  2. Group B: Control group. Assessments of the healing of ulcers will be performed at the baseline, post-treatment evaluation (ie, after 14 treatment sessions), and 1-month follow-up.

Outcome measures will include:

  1. Wound closure.
  2. Wound depth.
  3. Microcirculation.
03

Conditions studied

  • Diabetic Foot Ulcer

Browse trials for

Keywords

  • ulcer diabetic magnetic
04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. The ankle brachial index should fall between 0.9 and 1.2 to reassure that arterial insufficiency was not causing or contributing to the nonhealing wound.

      1. Patients diagnosed with diabetes with unsatisfactory healing of ulcer(s) in the preceding 4 weeks.
      1. Wagner grade 1 or 2 ulcers on the foot without exposure of bone, muscle, ligaments, or tendons.

Exclusion criteria

Exclusion Criteria:

  • 1- Ulcers secondary to non-diabetic etiology. 2- Poorly controlled diabetes. 3- Pregnancy. 4- Patients wearing a pacemaker or with or history of radiotherapy. 5- Patients who were taking medications that might affect their circulation or sensation and motor functioning and patients with any history of alcoholism were also excluded.

6- Patients who had clinical signs of infection or were taking antibiotics at the time of enrollment.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    group A

    Pulsed electromagnetic therapy will be delivered at the frequency of 12Hz, with magnetic flux density of 12G. Each treatment session will last for 1 hour, which will be repeated for 14 sessions within 3weeks. 20 patients will remain in the study until the wound heals or 14 sessions will be completed, whichever came first

    Device: pulsed electromagnetic currant machine

  • Placebo comparator
    Group B

    20 patients will receive intervention by using the same PEMF unit, but the output will be shut off.

    Other: Placebo

Interventions

  • Devicepulsed electromagnetic currant machine

    Pulsed electromagnetic therapy will be delivered at the frequency of 12Hz, with magnetic flux density of 12G. Each treatment session will last for 1 hour, which will be repeated for 14 sessions within 4weeks.

  • OtherPlacebo

    control group will receive intervention by using the same PEMF unit, but the output will be shut off.

06

What researchers measure

Primary outcomes

  1. ulcer size

    smart phone applications used to calculate wound size

    Time frame: 4 weeks

  2. Doppler ultrasonography

    used to calculate wound depth and microcirculation angiogenesis

    Time frame: 4 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Kwan RL, Cheing GL, Vong SK, Lo SK. Electrophysical therapy for managing diabetic foot ulcers: a systematic review. Int Wound J. 2013 Apr;10(2):121-31. doi: 10.1111/j.1742-481X.2012.01085.x. Epub 2012 Sep 7. PubMed 22958779 ↗

Individual participant data

Plan to share: Undecided — i dont know

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2025; primary completion for May 2025, 3 months later.

Of 243 non-industry interventional studies with no phase under Diabetic Foot, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 3 months is below that.

Counting every sponsor, half of 347 studies reached it within 22 months; a quarter within 9 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2025
First posted
Feb 5, 2025
StartEst.
Feb 1, 2025
Primary completionEst.
May 1, 2025
CompletionEst.
Aug 1, 2025
Last update
Feb 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06808191
Responsible party
Mahmoud Awad Ramadan Elkholy (lecturer of physical therapy for integumentary system disorders, Beni-Suef University) — Principal investigator
First posted
Feb 5, 2025
Start date
Feb 1, 2025 (estimated)
Primary completion
May 1, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
Feb 5, 2025

Study contacts

Mahmoud awd elkholy, lecturer of physical therapy
Contact
elkholym774@gmail.com
00201125746573
heba mohamed ali, Professor of Physical therapy
Contact
elkholym774@gmail.com
00201006327885
heba mohamed ali, Professor of Physical therapy
study chair · beni suif university
mahmoud awd elkholy, lecturer of physical therapy
study director · beni suif university
asmaa ramadan kamel, physiotherapist
principal investigator · beni suif university

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion